Literature DB >> 4025703

Thirty year experience with predictive lumbar sympathectomy. Method for selection of patients.

C A Kruse.   

Abstract

An office or bedside procedure to predict benefit from or contraindications to lumbar sympathectomy has been presented. Significant benefit and no instance of paradoxic gangrene occurred in an experience of more than 30 years with the test. This personal series of over 70 patients illustrates significant benefits, including healing of gangrenous digits, successful ray (transmetatarsal) amputation, and relief of ischemic rest pain in selected patients, even in the absence of femoral (groin) pulses. A criterion of an increase of 2 degrees or more in skin temperature of the ipsilateral great toe after lumbar sympathetic block at the approximate levels of the second, third, and fourth lumbar vertebrae has proved to be an adequate parameter or indication of subsequent benefit from surgical lumbar sympathectomy. A favorable response is predictable by the method described.

Entities:  

Mesh:

Year:  1985        PMID: 4025703     DOI: 10.1016/0002-9610(85)90126-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Alteration in cardiovascular function and body surface temperature during percutaneous stereotactic upper thoracic ganglionectomy and sympathectomy in palmar hyperhidrotic patients.

Authors:  King-Shun Chuang; Wan-Cherng Liu; Jiang-Chuan Liu
Journal:  Clin Auton Res       Date:  2004-08       Impact factor: 4.435

2.  Endoscopic extraperitoneal lumbar sympathectomy.

Authors:  P Hourlay; G Vangertruyden; F Verduyckt; F Trimpeneers; J Hendrickx
Journal:  Surg Endosc       Date:  1995-05       Impact factor: 4.584

3.  Recovery of sympathetic nerve function after lumbar sympathectomy is slower in the hind limbs than in the torso.

Authors:  Zhi-Fang Zheng; Yi-Shu Liu; Xuan Min; Jian-Bing Tang; Hong-Wei Liu; Biao Cheng
Journal:  Neural Regen Res       Date:  2017-07       Impact factor: 5.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.